BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9665488)

  • 1. Loss of heterozygosity on chromosome 11p15 during histological progression in microdissected ductal carcinoma of the breast.
    Lichy JH; Zavar M; Tsai MM; O'Leary TJ; Taubenberger JK
    Am J Pathol; 1998 Jul; 153(1):271-8. PubMed ID: 9665488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis.
    Winqvist R; Hampton GM; Mannermaa A; Blanco G; Alavaikko M; Kiviniemi H; Taskinen PJ; Evans GA; Wright FA; Newsham I
    Cancer Res; 1995 Jun; 55(12):2660-4. PubMed ID: 7780982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
    Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type ("clinging ductal carcinoma in situ"): a simulator of normal mammary epithelium.
    Moinfar F; Man YG; Bratthauer GL; Ratschek M; Tavassoli FA
    Cancer; 2000 May; 88(9):2072-81. PubMed ID: 10813719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of microsatellite instability at chromosome 11p15.5 in the progression of breast ductal carcinoma.
    Kim DJ; Park JY; Lee MH; Sohn YK
    J Korean Med Sci; 2004 Oct; 19(5):698-703. PubMed ID: 15483347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity from the short arm of chromosome 8 is associated with invasive behavior in breast cancer.
    Yaremko ML; Kutza C; Lyzak J; Mick R; Recant WM; Westbrook CA
    Genes Chromosomes Cancer; 1996 Jul; 16(3):189-95. PubMed ID: 8814452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern of chromosome 16q loss differs between an atypical proliferative lesion and an intraductal or invasive ductal carcinoma occurring subsequently in the same area of the breast.
    Tsuda H; Takarabe T; Akashi-Tanaka S; Fukutomi T; Hirohashi S
    Mod Pathol; 2001 May; 14(5):382-8. PubMed ID: 11353046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer.
    Zhuang Z; Merino MJ; Chuaqui R; Liotta LA; Emmert-Buck MR
    Cancer Res; 1995 Feb; 55(3):467-71. PubMed ID: 7834608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic loss of chromosomal arm 8p in breast cancer progression.
    Anbazhagan R; Fujii H; Gabrielson E
    Am J Pathol; 1998 Mar; 152(3):815-9. PubMed ID: 9502423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast.
    Chuaqui RF; Zhuang Z; Emmert-Buck MR; Liotta LA; Merino MJ
    Am J Pathol; 1997 Jan; 150(1):297-303. PubMed ID: 9006344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation at chromosome 11q23 in human non-familial breast cancer: a microdissection microsatellite analysis.
    Koreth J; Bethwaite PB; McGee JO
    J Pathol; 1995 May; 176(1):11-8. PubMed ID: 7616353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis.
    Shen CY; Yu JC; Lo YL; Kuo CH; Yue CT; Jou YS; Huang CS; Lung JC; Wu CW
    Cancer Res; 2000 Jul; 60(14):3884-92. PubMed ID: 10919664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High frequency of loss of allelic integrity at Wilms' tumor suppressor gene-1 locus in advanced breast tumors associated with aggressiveness of the tumor.
    Gupta S; Joshi K; Wig JD; Arora SK
    Indian J Cancer; 2009; 46(4):303-10. PubMed ID: 19749460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q.
    Radford DM; Fair KL; Phillips NJ; Ritter JH; Steinbrueck T; Holt MS; Donis-Keller H
    Cancer Res; 1995 Aug; 55(15):3399-405. PubMed ID: 7614479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic significance of loss of heterozygosity in breast cancer].
    Iwase H; Iwata H; Toyama T; Hara Y; Omoto Y; Kobayashi S
    Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():426-30. PubMed ID: 9589047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity in sporadic human breast carcinoma: a common region between 11q22 and 11q23.3.
    Hampton GM; Mannermaa A; Winqvist R; Alavaikko M; Blanco G; Taskinen PJ; Kiviniemi H; Newsham I; Cavenee WK; Evans GA
    Cancer Res; 1994 Sep; 54(17):4586-9. PubMed ID: 8062246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity in ductal carcinoma in situ of the breast.
    Stratton MR; Collins N; Lakhani SR; Sloane JP
    J Pathol; 1995 Feb; 175(2):195-201. PubMed ID: 7738715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.
    Phelan CM; Borg A; Cuny M; Crichton DN; Baldersson T; Andersen TI; Caligo MA; Lidereau R; Lindblom A; Seitz S; Kelsell D; Hamann U; Rio P; Thorlacius S; Papp J; Olah E; Ponder B; Bignon YJ; Scherneck S; Barkardottir R; Borresen-Dale AL; Eyfjörd J; Theillet C; Thompson AM; Larsson C
    Cancer Res; 1998 Mar; 58(5):1004-12. PubMed ID: 9500463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity at 11q23.1 and survival in breast cancer: results of a large European study. Breast Cancer Somatic Genetics Consortium.
    Laake K; Launonen V; Niederacher D; Gudlaugsdottir S; Seitz S; Rio P; Champème MH; Bièche I; Birnbaum D; White G; Sztan M; Sever N; Plummer S; Osorio A; Broeks A; Huusko P; Spurr N; Borg A; Cleton-Jansen AM; van't Veer L; Benitez J; Casey G; Peterlin B; Olah E; Børresen-Dale AL
    Genes Chromosomes Cancer; 1999 Jul; 25(3):212-21. PubMed ID: 10379867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions.
    Cleton-Jansen AM; Callen DF; Seshadri R; Goldup S; Mccallum B; Crawford J; Powell JA; Settasatian C; van Beerendonk H; Moerland EW; Smit VT; Harris WH; Millis R; Morgan NV; Barnes D; Mathew CG; Cornelisse CJ
    Cancer Res; 2001 Feb; 61(3):1171-7. PubMed ID: 11221848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.